Document:

Amended and Restated Stockholders Agreement

 EXHIBIT 10.7 
  
 EAGLE FAMILY FOODS HOLDINGS, INC. 
  
 AMENDED AND RESTATED 
 STOCKHOLDERS AGREEMENT 
  
 AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”), dated as of this 23rd day of November, 2004, by and among GE Investment Private Placement Partners II, a Limited Partnership (“GEI”), Warburg,
Pincus Ventures, L.P., a Delaware limited partnership (“Warburg”), Dairy Farmers of America Inc. (“DFA” and, together with GEI and Warburg, the “Institutional Investors”); the individuals whose
names and addresses appear from time to time on Schedule I hereto (the “Management Investors” and, together with the Institutional Investors, the “Investors”); and Eagle Family Foods Holdings, Inc., a Delaware
corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 6 hereof. 
  
 R E C I T A L S 
  
 WHEREAS, the Company, certain of the Investors and certain other parties entered into a Stockholders Agreement, dated as of January 23, 1998, as amended
on September 27, 1999 (the “Original Agreement”); 
  
 WHEREAS, certain of the Investors have agreed pursuant to the terms of Contribution and Exchange Agreements dated as of even date herewith (collectively, the “Contribution and Exchange Agreement”) to contribute to the
Company all of their shares of Common Stock of the Company, par value $0.01 per share (“Common Stock”), all of their shares of Series A Non-Voting Preferred Stock of the Company, par value $0.01 per share (the “Series A
Preferred”), and all of their shares of Series B Non-Voting Preferred Stock of the Company, par value $0.01 per share (the “Series B Preferred”), in exchange for the issuance by the Company of new shares of Common Stock.

  
 WHEREAS, one of the Investors has agreed pursuant to the terms
of an Asset Purchase Agreement dated as of even date herewith (the “Purchase Agreement” and, together with the Contribution and Exchange Agreement, the “Transaction Agreements”) to purchase shares of Common Stock
and shares of Series I Non-Voting Preferred Stock, par value $0.01 per share (the “the “Preferred Stock”). 
  
 WHEREAS, the Company has granted the Investors certain registration rights with respect to the Common Stock held by them pursuant to an amended and
restated registration rights agreement, dated as of the date hereof (the “Registration Rights Agreement”); and 
  
 WHEREAS, the Investors and the Company desire to amend and restate the Original Agreement to promote their mutual interests by agreeing to certain matters
relating to the operations of the Company and the disposition and voting of the shares of Common Stock and Preferred Stock purchased or received by the Investors pursuant to the Transaction Agreements, as applicable, together with any other shares
of Common Stock or Preferred Stock acquired by them (collectively, the “Shares”). 

 NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained, the parties
hereto hereby agree as follows: 
  
 1. COVENANTS OF THE PARTIES

  
 (a) Legends. The certificates evidencing the Shares
acquired by the Investors pursuant to the Transaction Agreements or their permitted transferees will bear the following legend reflecting the restrictions on the transfer of such securities contained in this Agreement: 
  
 “The securities evidenced hereby are subject to the terms of that
certain Amended and Restated Stockholders Agreement, dated as of November 23, 2004, by and among the Company and certain holders of the Company’s Common Stock and Preferred Stock, including certain preemptive rights, restrictions on transfer
and rights of co-sale. A copy of such Amended and Restated Stockholders Agreement has been filed with the Secretary of the Company and is available upon request.” 
  
 (b) Election of Directors. 
  

(i) As of the date hereof, the Board of Directors of the Company (the “Board”) will consist of Craig A. Steinke
(“Steinke”), Andreas T. Hildebrand, Kewsong Lee, David A. Barr, Mark J. Strelecki, Donald W. Torey, Jeffrey G. Goldfaden, and Gerald L. Bos. From and after the date hereof, the Investors and the Company shall take all action within
their respective power, including but not limited to, the voting of all shares of capital stock of the Company owned by them, required to cause the Board to consist of eight members or such other number as the Board may from time to time establish,
and at all times throughout the term of this Agreement to include (A) as long as Warburg owns beneficially (within the meaning of Rule 13d-3 under the Exchange Act) (1) at least twenty percent (20%) of the Common Stock, three (3) representatives
designated by Warburg, (2) at least fifteen percent (15%) of the Common Stock, two (2) representatives designated by Warburg and (3) at least ten percent (10%) of the Common Stock, one (1) representative designated by Warburg (each, a
“Warburg Director”), (B) as long as GEI owns beneficially (within the meaning of Rule 13d-3 under the Exchange Act) (1) at least twenty percent (20%) of the Common Stock, three (3) representatives designated by GEI, (2) at least
fifteen percent (15%) of the Common Stock, two (2) representatives designated by GEI and (3) at least ten percent (10%) of the Common Stock, one (1) representative designated by GEI (each, a “GEI Director”), (C) as long as DFA owns
beneficially (within the meaning of Rule 13d-3 under the Exchange Act), at least ten percent (10%) of the Common Stock, one (1) representative designated by DFA (the “DFA Director” and, together with each Warburg Director and each
GEI Director, the “Institutional Directors”), (D) as long as Warburg and GEI collectively own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) at least fifty percent (50%) of the Common Stock, Warburg and GEI
shall collectively have the right to designate that number of representatives as shall constitute a majority of the Board, and (E) Steinke, who shall be entitled to be a member of the Board in accordance with the terms of his employment agreement
with the Company as in effect from time to time. 
  
 (ii) In the
event that any Institutional Director is unable to serve, or once having commenced to serve, is removed or withdraws from the Board (a “Withdrawing Director”), such Withdrawing Director’s replacement (the “Substitute
Director”) will be 

 designated by the Institutional Investor having nominated such Institutional Director. An Institutional Director may be
removed, with or without cause, by the Institutional Investor having nominated such Institutional Director, and such Institutional Investor shall thereafter have the right to nominate a replacement for such Institutional Director. The Investors and
the Company agree to take all action within their respective power, including but not limited to, the voting of all shares of capital stock of the Company owned by them, to cause the election of such Substitute Director promptly following his or her
nomination pursuant to this Section 1(b)(ii). 
  
 (iii) Without
the consent of a majority of the Board, which majority shall include, as long as GEI is entitled to designate a director pursuant to this Section 1, at least one (1) GEI Director and, as long as Warburg is entitled to designate a director pursuant
to this Section 1, at least one (1) Warburg Director and, as long as DFA is entitled to designate a director pursuant to this Section 1, at least one (1) DFA Director, the Company, other than with respect to transactions contemplated under Sections
1(b)(iv)(A) and (B) herein, shall not, and shall cause Eagle Family Foods, Inc. and each of their respective Subsidiaries not to: 
  
 (A) approve any annual budget (the “Budget”) or any material amendment or modification thereto; 
  
 (B) make or incur any capital expenditures or investments not contemplated
by the Budget in excess of $500,000; 
  
 (C) (1) liquidate or
dissolve, (2) file, or consent by answer or otherwise to the filing against it of, a petition for relief or reorganization or arrangement or any other petition in bankruptcy, for liquidation or to take advantage of any bankruptcy, insolvency,
reorganization, moratorium or other similar law of any jurisdiction, (3) make an assignment for the benefit of its creditors, or (4) consent to the appointment of a custodian, receiver, trustee or other officer with similar powers with respect to it
or with respect to any substantial part of its property; 
  
 (D)
acquire any business (whether by acquisition of assets, stock or otherwise); 
  
 (E) issue any equity securities other than Plan Stock (each, as defined in Section 1(c)(i) hereof); 
  
 (F) incur any indebtedness for borrowed money, other than indebtedness outstanding on the date hereof (including additional borrowings permitted under
the facilities in effect on the date hereof); 
  
 (G) enter into
any new line of business; 
  
 (H) enter into any joint venture or
strategic alliance with any Person; 
  
 (I) enter into any
agreement having a duration in excess of one (1) year and cumulative obligations in excess of $1,000,000; 

 (J) sell or contribute, other than sales of inventory in the ordinary course of business or a sale of
all or substantially all of the assets of the Company, assets in excess of $500,000. 
  
 (K) pay or declare any dividend, or repurchase or redeem any shares of capital stock; 
  
 (L) amend or modify the Company’s Certificate of Incorporation or bylaws; 
  
 (M) amend, modify or terminate any employment agreement between the Company and any executive officer of the Company;

  
 (N) grant any stock options or other equity-based awards, or
authorize any senior management compensation plans or arrangements; 
  
 (O) hire or fire any executive officer of the Company; 
  
 (P) enter into any transaction with any officer, director or Affiliate of the Company (including, without limitation, GEI, Warburg or DFA); 
  
 (Q) make any loan or guarantee the indebtedness of any Person, except in the ordinary course of business; 
  
 (R) enter into, amend, modify or terminate any agreement, including any
collective bargaining agreement, with any union; 
  
 (S) approve
or adopt, amend, modify or terminate any stock plan, 401(k) plan, defined benefit or defined contribution plan or similar employee benefit plan; or 
  
 (T) enter into any agreement to do any of the foregoing. 
  
 (iv) Without the consent of a majority of the Board, which majority shall include, as long as GEI is entitled to designate a director pursuant to this
Section 1, at least one (1) GEI Director and, as long as Warburg is entitled to designate a director pursuant to this Section 1, at least one (1) Warburg Director, the Company shall not, and shall cause Eagle Family Foods, Inc. and each of their
respective Subsidiaries not to (A) merge or consolidate with any other Person (other than a merger or consolidation with a wholly owned subsidiary of the Company) and (B) sell or contribute all or substantially all of the assets of the Company.

  
 (c) Subscription Right. 
  
 (i) If at any time after the date hereof, the Company proposes to sell in
any non-public offering equity securities of any kind (the term “equity securities” shall include for these purposes any warrants, options or other rights to acquire equity securities and debt securities convertible into equity securities,
voting or other rights, and derivative securities of equity securities) of the Company (except (A) for grants or issuances after the date hereof pursuant to the Transaction Agreements, (B) for grants or issuances of equity securities pursuant

 to any incentive plan for the Company’s or any of its Subsidiaries’ directors or employees (collectively,
“Plan Stock”), (C) to the public in a firm commitment underwriting pursuant to a registration statement filed under the Securities Act, or (D) pursuant to the acquisition of another corporation by the Company by merger, purchase of
substantially all of the assets or other form of reorganization), then, as to each Investor who then holds shares of capital stock of the Company, the Company shall: 
  
 (1) give written notice setting forth in reasonable detail (I) the designation and all of the terms and
provisions of the equity securities proposed to be issued (the “Proposed Securities”), including, where applicable, the voting powers, preferences and relative participating, optional or other special rights, and the qualifications,
limitations or restrictions thereof and interest or dividend rate and maturity; (II) the price and other terms of the proposed sale of such Proposed Securities; (III) the amount of the Proposed Securities proposed to be issued; and (IV) such other
information as may be reasonably required in order to evaluate the proposed issuance; and 
  
 (2) offer to sell to each such Investor a portion of the Proposed Securities equal to a percentage determined by dividing (I) the number
of shares of Common Stock then held by such Investor (other than Plan Stock) by (II) the total number of shares of Common Stock then outstanding (other than Plan Stock). 
  
 (ii) Each such Investor must exercise its purchase rights hereunder within ten (10) days after receipt of such notice from
the Company. If all of the Proposed Securities offered to such Investors are not fully subscribed by such Investors, such remaining Proposed Securities will be reoffered to those Investors purchasing their full allotment upon the terms set forth in
this Section 1(c) (with an allocation based on the respective percentages of the aggregate number of shares of Common Stock held by such Investors), until all such Proposed Securities are fully subscribed for or until all such Investors have
subscribed for all such Proposed Securities which they desire to purchase, except that such Investors must exercise their purchase rights within five (5) days after receipt of all such reoffers. To the extent that the Company offers two (2) or more
equity securities in units, Investors must purchase such units as a whole and will not be given the opportunity to purchase only one of the equity securities making up such unit. 
  
 (iii) Upon the expiration of the offering periods described above, the Company will be free to sell such Proposed Securities
that the Investors have not elected to purchase during the ninety (90) days following such expiration on terms and conditions no more favorable to the purchasers thereof than those offered to such Investors. Any Proposed Securities offered or sold
by the Company after such 90-day period must be reoffered to the Investors pursuant to this Section 1(c). The election by an Investor not to exercise its subscription rights under this Section 1(c) in any one instance shall not affect its right
(other than in respect of a reduction in its percentage holdings) as to any subsequent proposed issuance. Any sale of equity securities by the Company without first giving the Investors the rights described in this Section 1(c) shall be void and of
no force and effect and the Company shall cause any correction required to be fully effected. 

 (iv) Notwithstanding anything contained in this Section 1(c), in the event that the issuance and sale of
the Proposed Securities to any Investor would require either a registration under the Securities Act or the preparation of a disclosure document pursuant to Regulation D under the Securities Act (or any successor regulation) or a similar provision
of any state securities law, then, at the option of the Board, such Investor or Investors may be excluded from the rights provided by this Section 1(c). 
  
 (d) No Inconsistent Agreements. Each of the Investors and the Company agrees that it will not and will not permit any Affiliate to grant any proxy
or enter into or agree to be bound by any voting trust with respect to its shares of capital stock of the Company or enter into any stockholder agreements or arrangements of any kind with any person with respect to its shares of capital stock of the
Company, in any such case in a manner that is inconsistent with the provisions of this Agreement. 
  
 2. TRANSFER OF STOCK BY MANAGEMENT INVESTORS. Without the approval of the Board, no Management Investor shall Transfer any Shares, or any
beneficial interest therein, other than Permitted Transfers between such Management Investor and the Company. Notwithstanding the foregoing, if, pursuant to the Registration Rights Agreement, a Management Investor is prevented by the Company’s
underwriter or underwriters from Transferring Shares in a public offering of Shares by the Company in which the Institutional Investors Transferred Shares, then following such public offering, and after the expiration of any applicable restrictions
on the Transfer of such Management Investor’s Shares under agreements not to sell, “lock-up” agreements or similar agreements to which the Management Investor is bound, such Management Investor shall be entitled to Transfer his pro
rata portion of Shares (to be calculated pursuant to the following sentence) that he would otherwise have been entitled to Transfer in such public offering without the approval of the Board, provided that (a) such Management Investor informs the
Board in writing of his intention to Transfer Shares at least seven days in advance of the proposed Transfer, such notice to include the number of Shares he intends to Transfer and (b) such Management Investor complies with all applicable securities
laws, including, without limitation, compliance with the volume and time limitations imposed by Rule 144 under the Securities Act. For purposes of the foregoing sentence, such Management Investor’s pro rata portion of Shares shall be equal to
(a) the product of (i) the aggregate number of Shares Transferred by the Institutional Investors in such public offering and (ii) the aggregate number of Shares beneficially owned by such Management Investor at the time of such public offering
divided by (b) the aggregate number of Shares held by the Institutional Investors at the time of such public offering; provided, however, that the pro rata portion as so calculated shall be adjusted downward to the extent the Board
shall have approved a Transfer of Shares by such Management Investor prior to such Management Investor’s notification to the Board of his intention to avail himself of this provision. Any Transfer or purported Transfer made in violation of this
Section 2 shall be null and void and of no effect. 
  
 3.
TRANSFER RIGHTS 
  
 (a) Right of Co-Sale. In the
event that any Investor intends to Transfer (i) shares of Common Stock which, together with any previous sales of shares of Common Stock by such Investor, represent more than twenty percent (20%) of its shares of Common Stock on a cumulative basis
or (ii) shares of Preferred Stock which, together with any previous sales of 

 Preferred Stock by such Investor represent twenty (20%) of its shares of Preferred Stock on a cumulative basis (in each
case other than to an Affiliate of such Investor), such Investor (the “Co-Sale Triggering Investor”) shall notify each other Investor holding shares of such class of stock, in writing, of such Transfer and its terms and conditions
(the “Proposed Sale”). Within ten (10) days after the date of such notice, each Investor holding shares of such class of stock that wishes to participate in the Proposed Sale (the “Co-Sale Investors”) shall so
notify the Co-Sale Triggering Investor in writing (a “Transfer Notice”). In the event the Co-Sale Triggering Investor fails to receive a Transfer Notice from any Investor within such 10-day period, such Investor shall be deemed to
have declined to participate in-the Proposed Sale. Each Co-Sale Investor shall have the right to sell, at the same price and on the same terms as the Co-Sale Triggering Investor, that number of shares of Common Stock or Preferred Stock, as the case
may be, equal to the number of shares of Common Stock or Preferred Stock, as the case may be the third party proposes to purchase multiplied by a fraction, the numerator of which shall be the number of shares of Common Stock or Preferred Stock
(other than Plan Stock), as the case may be, issued and owned by such Co-Sale Investor and the denominator of which shall be the aggregate number of shares of Common Stock or Preferred Stock (other than Plan Stock), as the case may be, issued and
owned by the Co-Sale Triggering Investor and each other Co-Sale Investor (including such Co-Sale Investor) exercising its rights pursuant to this Section 3. Nothing contained herein shall obligate the Co-Sale Triggering Investor to consummate the
Proposed Sale or limit the Co-Sale Triggering Investor’s right to amend or modify the terms of the Proposed Sale in any respect; provided that the Investors are offered the opportunity to participate in the Proposed Sale on such amended
or modified terms. 
  
 (b) Drag Along Right. 
  
 (i) If at any time and from time to time after the date of this Agreement,
Warburg and GE (collectively, the “Majority Holders”) wish to (i) Transfer in a bona fide arms’ length sale all of their Shares to any Person or Persons who are not Affiliates of the Company or the Majority Holders, (ii)
approve any merger of the Company with or into any other Person who is not an Affiliate of the Company or the Majority Holders, or (iii) approve any sale of all or substantially all of the Company’s assets to any Person or Persons who are not
Affiliates of the Company or the Majority Holders (for purposes of this Section 3(b), such Person or Persons is referred to as the “Proposed Transferee”), the Majority Holders shall have the right (for purposes of Section 3(b), the
“Drag-Along Right”) to (x) in the case of a Transfer of the type referred to in clause (i), require each other Investor to sell to the Proposed Transferee all of his or its Shares (including any warrants or options to acquire
Shares) for the same per share consideration as proposed to be received by the Majority Holders (less, in the case of options or warrants, the exercise price for such options or warrants) then Owned by such Investor or (y) in the case of a merger or
sale of assets referred to in clauses (ii) or (iii), require each other Investor to vote all shares then Owned by such other Investor in favor of such transaction and to waive any dissenter or appraisal right such Investor may have under applicable
law. Each Investor agrees to take all steps necessary to enable him or it to comply with the provisions of this Section 3(b) to facilitate the Majority Holders’ exercise of a Drag-Along Right. 
  
 (ii) To exercise a Drag-Along Right, the Majority Holders shall give each
Investor a written notice (for purposes of this Section 3(b), a “Drag-Along Notice”) containing (1) the name and address of the Proposed Transferee and (2) the proposed purchase price, terms 

 of payment and other material terms and conditions of the Proposed Transferee’s offer. Each Investor shall
thereafter be obligated to sell or vote his or its Shares (including any warrants or options Owned by such Investor), provided that the sale to the Proposed Transferee is consummated within ninety (90) days of delivery of the Drag-Along
Notice. If the sale or merger is not consummated within such ninety (90)-day period, then each Investor shall no longer be obligated to sell such Investor’s Shares pursuant to that specific Drag-Along Right but shall remain subject to the
provisions of this Section 3(b). 
  
 (iii) Each Investor shall
execute and deliver such instruments of conveyance and transfer and take such other action, including executing any purchase agreement, merger agreement, indemnity agreement, escrow agreement or related documents, as may be reasonably required by
the Majority Holders or the Company in order to carry out the terms and provisions of this Section 3(b). If the transaction is structured as a merger or consolidation, each Investor shall waive any dissenters’ rights, appraisal rights or
similar rights in connection with the proposed transaction. If any Investor fails or refused to vote or sell his, her or its Shares as required by, or votes his, her or its Shares in contravention of, this Section 3(b), then such Investor hereby
grants to the Secretary of the Company an irrevocable proxy, coupled with an interest, to vote such Shares in accordance with the provisions of this Section 3(b), and hereby appoints the Secretary of the Company his, her or its attorney in fact, to
sell such Shares in accordance with the provisions of this Section 3(b). At the closing of the proposed transaction, each Investor shall deliver, against receipt of the consideration payable in such transaction, certificates representing the Shares
which the Investor owns, together with executed stock powers or other instruments of transfer acceptable to the Majority Holders. 
  
 Notwithstanding anything contained in this Section 3(b), in the event that all or a portion of the purchase price consists of securities and the sale of
such securities to the Investors would require either a registration under the Securities Act or the preparation of a disclosure document pursuant to Regulation D under the Securities Act (or any successor regulation) or a similar provision of any
state securities law, then, at the option of the Majority Holders, any one or more of the Investors may receive, in lieu of such securities, the fair market value of such securities in cash, as determined in good faith by the Board. 
  
 4. INFORMATION AS TO COMPANY AND RELATED COVENANTS 
  
 (a) Investor Financial Information. From and after the date hereof,
the Company shall deliver to each Investor owning beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than five percent (5%) of the issued and outstanding shares of Common Stock (except for the annual reports referred to in
(a)(ii) below, which shall be delivered to each Investor as long as such Investor owns any shares of Common Stock): 
  
 (i) Quarterly Statements. As soon as practicable, and in any event within forty-five (45) days after the close of each of the first three (3)
fiscal quarters of each fiscal year of the Company, a consolidated balance sheet, statement of income and statement of changes in cash flow of the Company and its Subsidiaries as of the close of such quarter and the portion of the Company’s
fiscal year ending on the last day of such quarter, all in reasonable detail and prepared in accordance with U.S. generally accepted accounting principles, consistently applied, subject to audit and year end adjustments, setting forth in each case
in comparative form the figures for the comparable period of the previous year; 

 (ii) Annual Statements. As soon as practicable after the end of each fiscal year of the Company,
and in any event within 120 days thereafter, a copy of the consolidated balance sheet, and consolidated statements of income, stockholders’ equity and changes in cash flow of the Company and its Subsidiaries for such year, setting forth in each
case in comparative form the figures for the previous fiscal year, all in reasonable detail and accompanied by an opinion thereon of independent certified public accountants of recognized national standing selected by the Company, which opinion
shall state that such financial statements fairly present the financial position and results of operations of the Company and its Subsidiaries on a consolidated basis and have been prepared in accordance with U.S. generally accepted accounting
principles consistently applied (except for changes in application in which such accountants concur) and that the examination of such accountants has been made in accordance with generally accepted auditing standards, and accordingly included such
tests of the accounting records and such other auditing procedures as were considered necessary in the circumstances. 
  
 (b) Director Materials. The Company shall prepare and deliver to each director of the Company: 
  
 (i) Monthly Financial Statements. As soon as practicable, and in any
event within 30 days after the close of each of month of each fiscal year of the Company, a consolidated balance sheet, statement of income and statement of changes in cash flow of the Company and its Subsidiaries as of the close of each month and
the portion of the Company’s fiscal year ending on the last day of such month, all in reasonable detail and prepared in accordance with U.S. generally accepted accounting principles, consistently applied, subject to audit and year end
adjustments, setting forth in each case in comparative form the figures for the comparable period of the previous year; 
  
 (ii) Business Plan; Projections. Sixty (60) days after the commencement of each fiscal year of the Company, an annual business plan of the Company
and projections of operating results, prepared on a monthly basis, and a three-year business plan of the Company and projections of operating results. Within 45 days of the close of each fiscal quarter of the Company, the Company shall provide its
directors with a comparison of actual year-to-date results with the corresponding budgeted figures; 
  
 (iii) Audit Reports. Promptly upon receipt thereof, one copy of each other financial report and internal control letter submitted to the Company by
independent accountants in connection with any annual, interim or special audit made by them of the books of the Company and its Subsidiaries; and 
  
 (iv) Requested Information. With reasonable promptness, the Company shall furnish each director with such other data and information as from time
to time may be reasonably requested. 

 The Company acknowledges that its obligations under this Section 4(b) shall not limit the rights of its
directors under applicable law to obtain information and other materials from the Company. 
  
 (c) Inspection. From and after the date hereof, the Company will permit each Investor owning beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than five percent (5%) of the issued and
outstanding shares of Common Stock or Preferred Stock, its nominee, assignee or its representative to visit and inspect any of the properties of the Company, to examine all its books of account, records, reports and other papers not contractually
required of the Company to be confidential or secret, to make copies and extracts therefrom, and to discuss its affairs, finances and accounts with its officers, directors, key employees and independent public accountants or any of them (and by this
provision the Company authorizes said accountants to discuss with said Investor, its nominee, assign and representatives the finances and affairs of the Company and its Subsidiaries), all at such reasonable times and as often as may be reasonably
requested. 
  
 (d) Limitation to Access. Notwithstanding
the rights and obligations set forth in Sections 4(a) and (b) herein, such rights and obligations relating to information constituting or containing confidential business, financial or other information of the Company or its Subsidiaries shall not
apply to any Management Investor who, directly or indirectly, whether as an individual or on his or her own account, or as a shareholder, partner, joint venturer, director, officer, employee, consultant and/or independent contractor of any person,
firm or organization or otherwise, owns, manages, controls or participates in the ownership, management or control of, or is employed or engaged by or otherwise affiliated or associated with, a corporation, partnership, proprietorship, firm,
association or other business entity or otherwise engages in any business that is engaged in any manner in, or otherwise competes with, the business of the Company. 
  
 (e) Confidentiality. As to so much of the information and other material furnished under or in connection with this
Agreement (whether furnished before, on or after the date hereof) as constitutes or contains confidential business, financial or other information of the Company or its Subsidiaries, each Investor covenants for itself and its directors, officers,
partners and stockholders that it will use due care to prevent its respective officers, directors, employees, counsel, accountants and other representatives from disclosing such information to persons other than their respective authorized
employees, counsel, accountants, stockholders, partners, limited partners and other authorized representatives; provided, however, that the Investor may disclose or deliver any information or other material disclosed to or received by the Investor
should such disclosure or delivery be required by law. 
  
 5.
TERMINATION. The Agreement shall terminate: 
  
 (a) upon
the closing of the Initial Public Offering, except for the provisions of Sections 1(b), 2 and 4(d), which shall remain in full force and effect following the closing of the Initial Public Offering; or 

 (b) on the date on which (i) a majority of the Institutional Investors, and (ii) the holders of a
majority of the shares of Common Stock held by Management Investors shall have agreed in writing to terminate this Agreement. 
  
 6. INTERPRETATION OF THIS AGREEMENT 
  
 (a) Terms Defined. As used in this Agreement, the following terms have the respective meaning set forth below: 
  
 Affiliate: any person or entity, directly or indirectly, controlling,
controlled by or under common control with such person or entity. 
  
 Exchange Act: the Securities Exchange Act of 1934, as amended. 
  
 Initial Investors: the Institutional Investors and the individuals whose names appear on Schedule I hereto on the date hereof. 
  
 Initial Public Offering: the completion of an underwritten initial public offering for shares of Common Stock
pursuant to a registration statement under the Securities Act resulting in net proceeds to the Company and/or any selling stockholders of not less than $25,000,000. 
  
 Owns, Own or Owned: shall mean beneficial ownership, assuming the conversion of all outstanding securities
convertible into Common Stock and the exercise of all outstanding options and warrants to acquire Common Stock. 
  
 Permitted Transferee: shall mean, in the case of a Management Investor, members of such Management Investor’s family, heirs, executors or
legal representatives or trusts for the benefit of such Management Investor or such Management Investor’s family, provided in each instance that such transferee agrees to be bound by the provisions of this Agreement as if such transferee
were an original signatory hereto. 
  
 Person: an
individual, partnership, joint-stock company, corporation, limited liability company, trust or unincorporated organization, and a government or agency or political subdivision thereof. 
  
 Security Securities: as defined in Section 2(1) of the Securities Act. 
  
 Securities Act: the Securities Act of 1933, as amended. 
  
 Subsidiary: a Person of which the Company owns, directly or
indirectly, more than fifty percent 50% of the Voting Stock. 
  
 Transfer: any sale, assignment, pledge, hypothecation, or other disposition or encumbrance, whether or not for consideration. 

 Voting Stock: securities of any class or classes of a Person the holders of which are ordinarily,
in the absence of contingencies, entitled to elect a majority of the directors (or Persons performing similar functions). 
  
 (b) Accounting Principles. Where the character or amount of any asset or amount of any asset or liability or item of income or expense is required
to be determined or any consolidation or other accounting computation is required to be made for the purposes of this Agreement, this shall be done in accordance with U.S. generally accepted accounting principles at the time in effect, to the extent
applicable, except where such principles are inconsistent with the requirements of this Agreement. 
  
 (c) Directly or Indirectly. Where any provision in this Agreement refers to action to be taken by any Person, or which such Person is prohibited
from taking, such provision shall be applicable whether such action is taken directly or indirectly by such Person. 
  
 (d) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to contracts
made and to be performed entirely within such State. 
  
 (e)
Section Headings. The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to constitute a part thereof. 
  
 7. MISCELLANEOUS 
  
 (a) Notices. 
  
 (i) All communications under this Agreement shall be in writing and shall be delivered by hand or by facsimile or mailed by overnight courier or by
registered or certified mail, postage prepaid: 
  
 (A) if to any
of the Management Investors, at the address or facsimile number of such Management Investor shown on Schedule I, or at such other address or facsimile number as the Management Investor may have furnished the other parties hereto in writing;

  
 (B) if to GEI, at 3003 Summer Street, Stamford, CT 06905,
Attention: Andreas Hildebrand (Fax No.: (203) 326-2495), or at such other address as GEI may have furnished the other parties hereto in writing; 
  
 (C) if to Warburg, at 466 Lexington Avenue, New York, New York 10017, Attention: Kewsong Lee (Fax No.: (212) 878-6162), or at such other address or
facsimile number as Warburg may have furnished the other parties hereto in writing; 
  
 (D) if to the Company, to Eagle Family Foods Holdings, Inc., 735 Taylor Road, Suite 200, Gahanna, OH 43230, Attention: Craig Steinke. (Fax No.: (614) 501-4423), or at such other address or facsimile numbers as it may
have furnished the other parties hereto in writing; 

 (E) if to DFA, at 10220 N. Ambassador Drive, Kansas City, Missouri 64153, Attention Gerald L. Bos (Fax
No.: (816) 801-6593, or at such other address or facsimile numbers as it may have furnished the other parties hereto in writing, and 
  
 (ii) Any notice so addressed shall be deemed to be given: if delivered by hand or by facsimile, on the date of such delivery, if a business day, otherwise
the first business day thereafter; if mailed by courier, on the first business day following the date of such mailing; and if mailed by registered or certified mail, on the third business day after the date of such mailing. 
  
 (b) Reproduction of Documents. This Agreement and all documents
relating thereto, including, without limitation, (i) consents, waivers and modifications relating hereto which may hereafter be executed, (ii) documents received by each Investors pursuant hereto and (iii) financial statements, certificates and
other information previously or hereafter furnished to each Investor, may be reproduced by each Investor by an photographic, photostatic, microfilm, microcard, miniature photographic or other similar process and each Investor may destroy any
original document so reproduced. All parties hereto agree and stipulate that any such reproduction shall be admissible in evidence as the original itself in any judicial or administrative proceeding (whether or not the original is in existence and
whether or not such reproduction was made by each Investor in the regular course. of business) and that any enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence. 
  
 (c) Successors and Assigns; No Third Party Beneficiaries. This
Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of the parties. Nothing in this Agreement shall confer upon any Person not a party to this Agreement any rights or remedies of any nature or kind
whatsoever under or by reason of this Agreement. 
  
 (d) Entire
Agreement; Amendment and Waiver. This Agreement, the Registration Rights Agreement, the Transaction Agreements and the Certificate of Incorporation of the Company constitute the entire understanding of the parties hereto relating to the subject
matter hereof and supersede all prior understandings among such parties. This Agreement may be amended, and the observance of any term of this Agreement may be waived, with (and only with) the written consent of (i) each of the Institutional
Investors and (ii) the holder or holders of a majority of the shares of Common Stock (other than Plan Stock and other than those shares held by the Institutional Investors or their respective Affiliates), which shall include Management Investors
holding a majority of such shares held by Management Investors. . 
  
 (e) Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and all of which together shall be considered one and the same agreement. 
  
 (f) Injunctive Relief. It is acknowledged that it will be impossible
to measure in money the damages that would be suffered if the parties fail to comply with certain of the obligations imposed on them by this Agreement, including, without limitation, those obligations set forth in Sections 1 and 2, and that in the
event of any such failure, an aggrieved person will be irreparably damaged and will not have an adequate remedy at law. Any such person shall, therefore, be entitled to injunctive relief and/or specific performance to enforce such obligations, and
if any action should be brought in equity to enforce any of such provisions of this Agreement, none of the parties hereto shall raise the defense that there is an adequate remedy at law. 

 IN WITNESS WHEREOF, the parties hereto have executed this Stockholders Agreement as of the date first
above written. 
  

			
	 EAGLE FAMILY FOODS HOLDINGS, INC.

		
	 By:
	 	 /s/ Craig A. Steinke

	 Name:
	 	Craig A. Steinke
	 Title:
	 	Chief Executive Officer and President
	
	GE INVESTMENT PRIVATE PLACEMENT PARTNERS II, A LIMITED PARTNERSHIP
		
	 By:
	 	GE Investment Management Incorporated,
	 	 	its General Partner
		
	 By:
	 	 /s/ Andreas Hildebrand

	 Name:
	 	Andreas Hildebrand
	 Title:
	 	Vice President
	
	 WARBURG, PINCUS VENTURES, L.P.

		
	 By:
	 	Warburg, Pincus & Co.,
	 	 	its General Partner
		
	 By:
	 	 /s/ David A. Barr

	 Name:
	 	David A. Barr
	 Title:
	 	Managing Director
	
	 DAIRY FARMERS OF AMERICA INC.

		
	 By:
	 	 
		
	 By:
	 	 Gerald L. Bos

	 Name:
	 	Gerald L. Bos
	 Title:
	 	Chief Financial Officer and Corporate
	 	 	Vice President/Finance
	
	 MANAGEMENT INVESTOR:

	
	 [Signature on following pages]

 Signature Page to Stockholders Agreement, dated as of November 23, 2004, among Eagle Family Foods Holdings, Inc., GE
Investment Private Placement Partners II, A Limited Partnership, Warburg, Pincus Ventures, L.P., Dairy Farmers of America Inc. and the Management Investor set forth below. 
  

	
	 /s/ Craig Steinke

	 Craig Steinke

 SCHEDULE I 
  
 Management Investors 
  
 Craig Steinke 
 19 Norfield Road 
 Westin, CT 06883 
 Tel: 203-454-5745Contribution and Exchange Agreement

 EXHIBIT 10.8 
  
 CONTRIBUTION AND EXCHANGE AGREEMENT 
  
 This Contribution and Exchange Agreement, dated as of November 23, 2004 (the “Agreement”), is entered into
by and among the institutional stockholders listed on Schedule I hereto (the “Stockholders”) and Eagle Family Foods Holdings, Inc., a Delaware corporation (the “Company”). 
  
 R E C I T A L S 
  
 WHEREAS, pursuant to the Amended and Restated Certificate of Incorporation of
the Company, the Company is authorized to issue 2,200,000 shares of capital stock, which consists of (i) 1,200,000 shares of common stock, par value $0.01 per share (“Common Stock”), and (ii) 1,000,000 shares of Preferred Stock, of
which (a) 816,750 shares have been designated as Series A Preferred Stock, par value $0.01 per share (“Series A Preferred”) and (b) 99 shares have been designated as Series B Preferred Stock, par value $0.01 per share
(“Series B Preferred” and, together with the Series A Preferred, the “Preferred Stock”); 
  
 WHEREAS, the Stockholders are the owners of the number of shares of Common Stock, Series A Preferred and Series B Preferred set forth opposite such
Stockholders’ names on Schedule II hereto (collectively, the “Shares”), representing all of the Shares owned by the Stockholders; 
  

WHEREAS, the Stockholders desire to contribute to the Company, and the Company desires to accept from the Stockholders, the Shares owned by them as a
contribution to capital (the “Contribution”), in exchange (the “Exchange”) for the issuance to the Stockholders of the number of shares of Common Stock set forth opposite such Stockholder’s name on Schedule
III hereto (collectively, the “New Shares”); and 
  
 WHEREAS, contemporaneously with the transactions contemplated by this Agreement, the Company shall (i) amend and restate the Company’s certificate of incorporation, among other things, to increase the number of authorized shares of
Common Stock and create a new series of preferred stock (the “Series I Preferred Stock”), (ii) issue 1,048,091 shares of Common Stock and 150 shares of Series I Preferred Stock to Dairy Farmers of America Inc. (“DFA”) pursuant to
that certain Asset Purchase Agreement, dated as of the date hereof, between the Company and DFA (the “New Equity Investment”), (iv) exchange all of the Preferred Stock and Common Stock owned by a certain management stockholder in
exchange for the issuance of new shares of Common Stock (the “Management Repurchase”); 
  
 NOW, THEREFORE, in consideration of the premises and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto, intending to be legally bound, agree as follows: 

 ARTICLE I. 
 CONTRIBUTION AND EXCHANGE 
  
 Section 1.1. Contribution. Effective as of the date hereof, each of the Stockholders hereby contributes, transfers, assigns and conveys to the Company all right, title and interest in and to all of the Shares owned by such
Stockholder, which Shares are set forth opposite such Stockholder’s name on Schedule II hereto, together with any and all rights, privileges, benefits, obligations and liabilities appertaining thereto, reserving unto such Stockholder no
rights or interests therein whatsoever, to have and to hold the same unto the Company and its heirs, legal representatives, successors and assigns, from and after the date hereof to its own proper use forever. Each Stockholder shall deliver all
stock powers and other instruments of transfer necessary to effect the Contribution. 
  
 Section 1.2. Acceptance of Contribution. The Company hereby accepts the Contribution of the Shares pursuant to Section 1.1 above. 
  
 Section 1.3. Exchange. In consideration of the Contribution by the Stockholders, effective as of the date
hereof, in exchange for the Shares the Company shall issue to the Stockholders the number of New Shares set forth opposite such Stockholder’s name on Schedule III hereto. At anytime after the date hereof and at the request of the
Stockholder, the Company shall issue to such Stockholder certificates registered in the Stockholder’s name representing the number of New Shares set forth opposite such Stockholder’s name on Schedule III hereto. 
  
 Section 1.4. Termination of Warrants. The Company and each of
the Stockholders hereby agree that all warrants to purchase shares of Common Stock owned by such Stockholders are hereby terminated and shall be of no further force and effect. 
  
 Section 1.5. Power of Attorney. Each Stockholder hereby constitutes and appoints the Company, its successors
and assigns, as the Stockholder’s true and lawful attorney-in-fact, with full power of substitution, in the name of the Company or in the name of the Stockholder, to execute, deliver, file and/or record such documents, agreements and
instruments as shall be necessary or appropriate to effect the Contributions pursuant to this Article I. The foregoing powers are coupled with an interest and shall be irrevocable. 
  
 ARTICLE II. 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
  
 The Company represents and warrants to each of the Stockholders as follows: 
  
 Section 2.1. Organization. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. 
  
 Section 2.2. Authority. The Company has all requisite corporate
power and authority to execute, deliver and perform this Agreement and the transactions contemplated hereby, including, without limitation, the issuance and delivery of the New Shares to the Stockholders in accordance with the terms of
this Agreement. No other corporate action is 
  

 -2- 

 necessary to authorize such execution, delivery and performance other than corporate actions already taken, and upon such
execution and delivery, this Agreement shall constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as enforceability may be (i) limited by bankruptcy, insolvency or other
similar laws affecting the enforcement of creditor’s rights, or (ii) subject to general principles of equity. 
  
 Section 2.3. Outstanding Capital Stock of the Company. Immediately prior to the consummation of the transactions contemplated by the
Agreement and consummation of the New Equity Investment and the Management Repurchase, the issued and outstanding capital stock of the Company in the amounts held beneficially and of record is as set forth on Schedule IV hereto. Immediately
following consummation of the transactions contemplated by this Agreement and consummation of the New Equity Investment, and the Management Repurchase, the issued and outstanding capital stock of the Company in the amounts held beneficially and of
record shall be as set forth on Schedule V hereto. 
  
 Section 2.4. Issuance of Shares. The New Shares to be issued by the Company pursuant to this Agreement, when issued in accordance with the provisions hereof, will be validly issued by the Company, fully paid and nonassessable
shares of the Company, and, no stockholder of the Company has, or will have, any preemptive rights to subscribe for any such New Shares other than rights which have been waived. 
  
 Section 2.5. Consents; Conflicts. Except with respect to filings made in connection with exemptions from
registration under state or federal securities laws, the creation, authorization, issuance, offer and sale of the New Shares do not require any consent, approval or authorization of, or filing, registration or qualification with, any Person or
governmental authority on the part of the Company or the vote, consent or approval in any manner of the holders of any security of the Company as a condition to the execution and delivery of this Agreement or the creation, authorization, issuance,
offer and sale of the New Shares. The execution and delivery by the Company of this Agreement and the performance by the Company of its obligations hereunder will not violate (i) the terms and conditions of the Restated Certificate of Incorporation
or the Bylaws of the Company, or any agreement or instrument to which the Company is a party or by which it is bound or (ii) subject to the accuracy of the Stockholders’ representations and warranties contained herein, including,
without limitation, the representations and warranties contained in Section 3.3 hereof, any federal or state law. 
  
 ARTICLE III. 
 REPRESENTATIONS AND
WARRANTIES OF THE STOCKHOLDERS 
  
 Each of the Stockholders,
severally and not jointly, represents and warrants to the Company as follows: 
  
 Section 3.1. Title to Securities. The Stockholder is the owner and holder of the respective number of shares of Common Stock and Preferred Stock set forth opposite such Stockholder’s name on
Schedule II hereto and has good and valid title to such Common Stock and Preferred Stock, free and clear of all liens, security interests, claims, charges, equities, pledges, options and encumbrances of any kind. 
  

 -3- 

 Section 3.2. Authority. The Stockholder has full right, power and authority to contribute,
transfer, assign and convey to the Company the full legal and beneficial ownership in the Shares to be surrendered by such Stockholder pursuant to this Agreement and to consummate the transactions contemplated herein. This Agreement has been duly
and validly executed and delivered by the Stockholder and is a legal, valid and binding obligation of such Stockholder enforceable in accordance with its terms, except as enforceability may be (i) limited by bankruptcy, insolvency or other similar
laws affecting the enforcement of creditor’s rights, or (ii) subject to general principles of equity. Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby nor compliance with any of
the provisions hereof will (a) result in any conflict with, breach of, or default (or give rise to any right of termination, cancellation or acceleration) under any of the terms, conditions or provisions of any agreement or other instrument or
obligation to which such Stockholder is a party or by which such Stockholder or any of such Stockholder’s properties or assets may be bound, or (b) violate any order, writ, injunction, judgment, decree, law, statute, rule or regulation
applicable to such Stockholder or any of such Stockholder’s properties or assets. No action, consent or approval by, or filing with, any Federal, state, municipal, foreign or other court or governmental or administrative body or agency, or any
other regulatory or self-regulatory body, is required in connection with the execution and delivery by the Stockholder of this Agreement or the consummation by such Stockholder of the transactions contemplated hereby. 
  
 Section 3.3. Accredited Investor. 
  
 (a) Offering Exemption. Each Stockholder acknowledges that the New
Shares have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), nor registered or qualified under any state securities laws, and that they are being offered and sold pursuant to an exemption from
such registration and qualification based in part upon such Stockholder’s representations contained herein. 
  
 (b) Knowledge of Offer. Each Stockholder is familiar with the business and operations of the Company and has been given the opportunity to obtain
from the Company all information that such Stockholder has requested regarding its business plans and prospects. 
  
 (c) Knowledge and Experience; Ability to Bear Economic Risks. Each Stockholder has such knowledge and experience in financial and business matters
that it is capable of evaluating the merits and risks of the investment contemplated by this Agreement, and is able to bear the economic risk of this investment in the Company (including a complete loss of the value of the New Shares). 

 
 (d) Limitations on Disposition. Each Stockholder recognizes that no
public market exists for the New Shares, and none may exist in the future. Each Stockholder acknowledges that it must bear the economic risk of this investment indefinitely unless such Stockholder’s New Shares are registered pursuant to the
Securities Act, or an exemption from such registration is available, and unless the disposition of such New Shares is qualified or registered under applicable state securities laws or an exemption from such qualification or registration is
available, and that the Company has no present intention of so registering the New Shares. Each Stockholder acknowledges that there is no assurance that any exemption from the 
  

 -4- 

 Securities Act will be available, or, if available, that such exemption will allow such Stockholder to transfer any or
all of the New Shares, in the amounts, or at the times such Stockholder might propose. Each Stockholder acknowledges that at the present time Rule 144 promulgated under the Securities Act by the Securities and Exchange Commission is not applicable
to sales of the New Shares. 
  
 (e) Accredited Investor.
Each Stockholder is an “accredited investor” as such term is defined in Rule 501(a) promulgated under the Securities Act. 
  
 Section 3.4. Capacity. The Stockholder has full power and legal right to execute and deliver this Agreement and to perform such
Stockholder’s obligations hereunder. 
  
 ARTICLE IV.

 COVENANTS OF THE PARTIES 
  
 Section 4.1. Further Assurances. Each Stockholder will execute and deliver, or cause to be executed and delivered, such additional or
further transfers, assignments, endorsements and other instruments as the Company may reasonably request for the purpose of effectively carrying out the transfer of the Shares and the other transactions contemplated by this Agreement. 
  
 ARTICLE V. 
 MISCELLANEOUS PROVISIONS 
  
 Section 5.1. Notices. All communications under this Agreement shall be in writing and shall be delivered by hand or facsimile or mailed by overnight courier or by registered mail or certified mail,
postage prepaid: 
  
 (a) if to the Stockholders, at the address
or facsimile number listed on Schedule I hereto, or at such other address or facsimile number as may have been furnished to the Company and the other Stockholders in writing, with a copy to Willkie Farr & Gallagher LLP, 787 Seventh
Avenue, New York, NY 10019 (facsimile: (212) 728-9222), Attention: Steven J. Gartner, Esq.; 
  
 (b) if to the Company, at 735 Taylor Road, Suite 200, Gahanna, OH 43230 (facsimile: (614) 501-4299), marked for attention of Chief Executive Officer, or at such other address or facsimile as the Company may have
furnished in writing to each of the Stockholders. 
  
 Any notice so addressed
shall be deemed to be given: if delivered by hand or facsimile, on the date of such delivery, if a business day and delivered during regular business hours, otherwise the first business day thereafter; if mailed by courier, on the first business day
following the date of such mailing; and if mailed by registered or certified mail, on the third business day after the date of such mailing. 
  
 Section 5.2. Amendments. The terms, provisions and conditions of this Agreement may not be changed, modified or amended in any manner except
by an instrument in writing duly executed by the Company and each of the Stockholders. 
  

 -5- 

 Section 5.3. Assignment; Parties in Interest. 
  
 (a) Assignment. Neither this Agreement nor any of the rights, duties,
or obligations of any party hereunder may be assigned or delegated by any party hereto except with the prior written consent of the Company and each of the Stockholders. 
  
 (b) Parties in Interest. This Agreement shall not confer any rights or remedies upon any Person other than the
parties hereto and their respective permitted successors and assigns. 
  
 Section 5.4. Expenses. All fees, costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such fees, costs and expenses. The Company shall pay
any liabilities (including interest and penalties) with respect to, or resulting from any delay or failure, in paying, stamp and other taxes, if any, which may be payable or determined to be payable on the execution and delivery of this Agreement or
acquisition of the New Shares pursuant to this Agreement. 
  
 Section 5.5. Entire Agreement. This Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof, supersedes and is in full substitution for any and all prior agreements and
understandings among them relating to such subject matter, and no party shall be liable or bound to the other party hereto in any manner with respect to such subject matter by any warranties, representations, indemnities, covenants or agreements
except as specifically set forth herein. The Schedules to this Agreement are incorporated herein and made a part hereof and are an integral part of this Agreement. 
  
 Section 5.6. Descriptive Headings. The descriptive headings of the several sections (including subsections) of
this Agreement are inserted for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof. 
  
 Section 5.7. Counterparts. For the convenience of the parties, any number of counterparts of this Agreement may be executed by any one or
more parties hereto (including by facsimile), and each such executed counterpart shall be, and shall be deemed to be, an original, but all of which shall constitute, and shall be deemed to constitute, in the aggregate but one and the same
instrument. 
  
 Section 5.8. Governing Law. This
Agreement and the legal relations among the parties hereto shall be governed by and construed in accordance with the laws of the State of Delaware, applicable to contracts made and performed therein. 
  
 Section 5.9. Construction. The language used in this Agreement
will be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction will be applied against any party. 
  
 Section 5.10. Severability. In the event that any one or more of the provisions contained in this Agreement or in any other instrument
referred to herein, shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, then to the maximum extent permitted by law, such invalidity, illegality or unenforceability shall not affect any other 
  

 -6- 

 provision of this Agreement or any other such instrument. Furthermore, in lieu of any such invalid, illegal or
unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid, illegal or unenforceable provision as may be possible and be valid, legal and
enforceable. 
  
 Section 5.11. Specific Performance.
Without limiting or waiving in any respect any rights or remedies of any party under this Agreement now or hereinafter existing at law or in equity or by statute, each of the parties hereto shall be entitled to seek specific performance of the
obligations to be performed by the other in accordance with the provisions of this Agreement. 
  
 Section 5.12. Survival of Provisions. The respective representations, warranties, covenants and agreements of each of the parties to this
Agreement shall survive the execution of this Agreement and the consummation of the transactions contemplated by this Agreement. 
  
 [Remainder of page intentionally left blank] 
  

 -7- 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed on the day and year
first above written. 
  

			
	 EAGLE FAMILY FOODS HOLDINGS, INC.

		
	 By:
	 	 /s/ Craig Steinke

	 Name:
	 	Craig A. Steinke
	 Title:
	 	Chief Executive Officer and President
	
	 WARBURG, PINCUS VENTURES, L.P.

		
	 By:
	 	Warburg Pincus & Co.,
	 	 	General Partner
		
	 By:
	 	 /s/ David Barr

	 Name:
	 	David Barr
	 Title:
	 	Managing Director
	
	GE INVESTMENT PRIVATE PLACEMENT PARTNERS II, A LIMITED PARTNERSHIP
		
	 By:
	 	GE Investment Management Incorporated,
	 	 	General Partner
		
	 By:
	 	 /s/ Andreas Hildebrand

	 Name:
	 	Andreas Hildebrand
	 Title:
	 	Vice President

 SCHEDULE I 
  

STOCKHOLDERS 
  
         Stockholder’s Name and Address 

  
 Warburg, Pincus Ventures, L.P. 
 c/o Warburg Pincus & Co. 
 466 Lexington Avenue 
 New York, NY 10017 
 Facsimile: (212) 878-3748 
 Attention: Kewsong Lee 
  
 GE Investment Private
Placement Partners II, 
 a Limited Partnership 
 3003 Summer
Street 
 Stamford, CT 06905 
 Facsimile: (203) 326-2495

 Attention: Andreas Hildebrand 

 SCHEDULE II 
  
 OWNERSHIP OF COMMON STOCK AND PREFERRED STOCK 
  

							
	 Stockholder

	  	Common
Stock

	  	Series A
Preferred

	  	Series B
Preferred

	 Warburg, Pincus Ventures, L.P.
	  	458,200	  	402,398.7735	  	49.5
	 GE Investment Private Placement Partners II, a Limited Partnership
	  	458,200	  	402,398.7735	  	49.5

  

 SCHEDULE III 
  
 OWNERSHIP OF NEW SHARES 
  

			
	 Stockholder

	 	 New Shares

	 Warburg, Pincus Ventures, L.P.
	 	621,542.50
	 GE Investment Private Placement Partners II, a Limited Partnership
	 	621,542.50

  

 SCHEDULE IV 
  
 PRE-TRANSACTION CAPITALIZATION 
  

							
	 Stockholder

	  	Common
Stock

	  	Series A
Preferred

	  	Series B
Preferred

	 Warburg, Pincus Ventures, L.P.
	  	458,200	  	402,398.7735	  	49.5
	 GE Investment Private Placement Partners II, a Limited Partnership
	  	458,200	  	402,398.7735	  	49.5
	 Craig A. Steinke
	  	40,835	  	990.0000	  	—  

  

 SCHEDULE V 
  

POST-TRANSACTION CAPITALIZATION 
  

					
	 Stockholder

	  	Common
Stock

	  	Series I
Preferred

	 Warburg, Pincus Ventures, L.P.
	  	621,542.50	  	—  
	 GE Investment Private Placement Partners II, a Limited Partnership
	  	621,542.50	  	—  
	 Dairy Farmers of America Inc.
	  	1,048,091.00	  	—  
	 Mid-Am Capital, L.L.C.
	  	—  	  	150
	 Craig A. Steinke
	  	95,547.00	  	—

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}]]